Literature DB >> 17253440

[Hyperprolactinemia: causes, diagnosis, and treatment].

Michał Karasek1, Marek Pawlikowski, Andrzej Lewiński.   

Abstract

The basic data on hyperprolactinemia (i.e. an excess of PRL above a reference laboratory's upper limits), the most common endocrine disorder of the hypothalamic-pituitary axis are given in this review. The following issues are discussed: regulation of prolactin (Prl) secretion, definition of hyperprolactinemia, its etiology and pathogenesis as well as its symptoms, diagnosis, and treatment (including medical and surgical therapy). It should be stressed that finding of elevated PRL serum concentrations constitute the beginning of diagnostic procedure and, after exclusion of physiologic, pharmacologic, and other organic causes of increased PRL levels, should be followed by detailed diagnosis including MRI. In patients in whom hyperprolactinemia has been confirmed the treatment with dopamine agonists (with prevalence of cabergoline, followed by quinagoline) is currently considered first-choice therapy. Surgery should be performed only in the patients resistant or intolerant to these agents, or in patients who refuse long-term therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17253440

Source DB:  PubMed          Journal:  Endokrynol Pol        ISSN: 0423-104X            Impact factor:   1.582


  6 in total

1.  Endocrine sequelae of cancer and cancer treatments.

Authors:  Charles J Stava; Camilo Jimenez; Rena Vassilopoulou-Sellin
Journal:  J Cancer Surviv       Date:  2007-11-20       Impact factor: 4.442

2.  Hyperprolactinaemia - a problem in patients from the reproductive period to the menopause.

Authors:  Sylwia Pałubska; Aneta Adamiak-Godlewska; Izabela Winkler; Katarzyna Romanek-Piva; Tomasz Rechberger; Marek Gogacz
Journal:  Prz Menopauzalny       Date:  2017-04-26

3.  Long-term Use of Clozapine is Protective for Bone Density in Patients with Schizophrenia.

Authors:  Chieh-Hsin Lin; Chun-Yuan Lin; Hong-Song Wang; Hsien-Yuan Lane
Journal:  Sci Rep       Date:  2019-03-07       Impact factor: 4.379

4.  Prolactin Level in Polycystic Ovary Syndrome (PCOS): An approach to the diagnosis and management.

Authors:  Zahra Davoudi; Farnaz Araghi; Maryam Vahedi; Navid Mokhtari; Mehdi Gheisari
Journal:  Acta Biomed       Date:  2021-11-03

5.  Prevalence of macroprolactinaemia in regularly menstruating women with non-toxic goitre or autoimmune thyroid disease.

Authors:  Krzysztof C Lewandowski; Danuta Gąsior-Perczak; Aldona Kowalska; Andrzej Lewiński
Journal:  Thyroid Res       Date:  2012-12-17

6.  Randomized controlled trial comparing changes in serum prolactin and weight among female patients with first-episode schizophrenia over 12 months of treatment with risperidone or quetiapine.

Authors:  Jianjun Liu; Jushui Sun; Xinghua Shen; Weigang Guo; Shengli Zhi; Guangming Song; Qiuxia Xu; Juanfen Song
Journal:  Shanghai Arch Psychiatry       Date:  2014-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.